Company / Current Liabilities per Share
Axsome Therapeutics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$7.78
FY2025
5-year range
$0.61 / $7.78
FY2021-FY2025
Trend
+60.2%
vs FY2024
Sector context
#28 of 210
Health Care
What the data says
Axsome Therapeutics, Inc.'s current liabilities per share of $7.78 is higher than 87% of companies in the Health Care sector (FY2025). Current Liabilities per Share has increased for 4 consecutive years, from $0.61 in FY2021 to $7.78 in FY2025.
Based on SEC 10-K filings.
7.78 in FY2025 with a 5-year CAGR of +65.3%. Top quartile in the Health Care sector.
Increased from $3.19 to $7.78 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +45.0%
- 5-Year CAGR
- +65.3%
- 10-Year CAGR
- -
Sector benchmark
-67.3% below sector average
Key checks
Key Insights
- Axsome Therapeutics, Inc.'s current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 60.2% year-over-year.
- Ranks #28 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.78 | +60.2% |
| FY2024 | $4.86 | +52.2% |
| FY2023 | $3.19 | +25.0% |
| FY2022 | $2.55 | +316.4% |
| FY2021 | $0.61 | -2.7% |
| FY2020 | $0.63 | -12.5% |
| FY2019 | $0.72 | +78.9% |
| FY2018 | $0.40 | -24.7% |
| FY2017 | $0.53 | +42.8% |
| FY2016 | $0.37 | +69.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026